跳至主要内容
临床试验/NCT01381770
NCT01381770已完成2 期

Platelet-derived Factors for Treatment of Muscular Lesions: a Phase II Trial

Fondazione IRCCS Policlinico San Matteo di Pavia2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25
试验地点
2
主要终点
number (and proportion with 95% CI) of patients able to return to sport activity (i.e. training) at 21 days from muscular injury.

研究概览

简要总结

The purpose of this study is to demonstrate that platelet-derived repairing factors are effective and safe in the treatment of muscular lesion grade 2 or 3, a Phase II, open-label, single arm, single centre has been designed. Sample size will be 25.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 years old
  • if woman, no pregnancy ongoing
  • muscular lesion grade 2 or 3 in a lower limb muscular group

排除标准

  • no hematological conditions
  • no anticoagulation in the two preceding weeks

结局指标

主要结局

number (and proportion with 95% CI) of patients able to return to sport activity (i.e. training) at 21 days from muscular injury.

时间窗: 21 days from enrollment

If the athlete is able, 21 days after the muscular injury, to return to (at least) training activities, the outcome will be coded "successful"; and "unsuccessful" otherwise

次要结局

  • time-to-healing at ultrasound(within 4 months from treatment)
  • Time-to-return to sport activities(within 4 months from lesion)
  • Side effects(within 4 months from treatment)
  • side effects(within 4 months from treatment)

研究者

发起方
Fondazione IRCCS Policlinico San Matteo di Pavia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Claudio Pavesi

MD

Fondazione IRCCS Policlinico San Matteo di Pavia

研究点 (2)

Loading locations...

相似试验